Portfolio Companies 2026 for Syncona: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Syncona accounts for 12 tracked companies with verified cap-table data, 12 of which disclose round sizes totalling $2.2B. The median disclosed raise is $160M, and the largest is Quell Therapeutics at $344M, ahead of Beacon Therapeutics ($290M) and AGTC ($290M).
The names that recur most often on these portfolio cap tables are Syncona (12 companies), Forbion (5 companies), Oxford Science Enterprises (3 companies), British Patient Capital (2 companies), TCGX (2 companies), Advent Life Sciences (2 companies). By latest disclosed round, the market skews Series B (7), Series A (3), Series C (1).
Companies tracked: 12
Disclosed funding total: $2.2B across 12 companies
